NKE vs RGNX · P/E 35, rev $46.40B vs rev $114.4M
Nike Inc (NKE) versus Regenxbio Inc (RGNX) — a side-by-side from cached financials, not a winner call.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by Elliott J. Hill.
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
NKE currently screens at market cap $110.14B and trailing P/E 34.6. RGNX currently screens at market cap $440.4M.
Not investment advice. Open the NKE and RGNX stock pages for the full models.
Not investment advice.